The Questionnaire for Measuring Factors of Aggression (Fragebogen zur Erfassung von Aggressivitätsfaktoren, FAF) was completed by 113 depressive patients, 38 psoriatics, and 32 healthy controls. The controls had the lowest aggression scores, the neurotic depressives the highest. The monopolar endogenous depressives had extremely high scores for autoaggressions and extremely low ones for outward aggressions, whereas the psoriatics show a contrary tendency: extremely high scores for outward aggressions and very low ones for autoaggressions.
A study of the partnerships of 15 endogenous bipolar, 15 endogenous unipolar, 15 neurotic and 16 unclassified depressives, and of 36 control persons showed that there were some common factors and some differences due to sex among the depressives as a total group. The greater differences were to be found, however, among the depressive subgroups. Bipolars: particularly great desire for closeness and for love and attention, low self-esteem where the partner is concerned, the strongest aggression inhibition. Unipolars: arrogance, indirect aggression and emotional distance to the partner. Neurotic depressives: many conflicts, directly and indirectly aggressive, dissatisfied and demanding. Unclassified depressives: extreme fluctuations between clinging and arrogance and withdrawal.
The parent-child relationship, the relationship between the parents, and the contact of the child with the outside world was investigated on the basis of retrospective interview data concerning the childhood of endogenous and neurotic depressives and a nonclinical control group. A number of significant links between childhood experiences and the various forms of depression emerges.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.